Bryan Giraudo - Net Worth and Insider Trading
Bryan Giraudo Net Worth
The estimated net worth of Bryan Giraudo is at least $1 Million dollars as of 2025-04-26. Bryan Giraudo is the Director of Protagonist Therapeutics Inc and owns about 18,000 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $800,820. Bryan Giraudo is also the COO/CFO of Gossamer Bio Inc and owns about 480,010 shares of Gossamer Bio Inc (GOSS) stock worth over $459,994. Details can be seen in Bryan Giraudo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bryan Giraudo has not made any transactions after 2024-06-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bryan Giraudo
Bryan Giraudo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bryan Giraudo owns 2 companies in total, including Gossamer Bio Inc (GOSS) , and Protagonist Therapeutics Inc (PTGX) .
Click here to see the complete history of Bryan Giraudo’s form 4 insider trades.
Insider Ownership Summary of Bryan Giraudo
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| GOSS | Gossamer Bio Inc | 2024-06-18 | Chief Financial Officer |
| PTGX | Protagonist Therapeutics Inc | 2022-05-26 | director |
Bryan Giraudo Latest Holdings Summary
Bryan Giraudo currently owns a total of 2 stocks. Among these stocks, Bryan Giraudo owns 18,000 shares of Protagonist Therapeutics Inc (PTGX) as of December 3, 2019, with a value of $800,820 and a weighting of 63.52%. Bryan Giraudo also owns 480,010 shares of Gossamer Bio Inc (GOSS) as of June 18, 2024, with a value of $459,994 and a weighting of 36.48%.
Latest Holdings of Bryan Giraudo
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2019-12-03 | 18,000 | 44.49 | 800,820 |
| GOSS | Gossamer Bio Inc | 2024-06-18 | 480,010 | 0.96 | 459,994 |
Holding Weightings of Bryan Giraudo
Bryan Giraudo Form 4 Trading Tracker
According to the SEC Form 4 filings, Bryan Giraudo has made a total of 0 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years. The most-recent trade in Protagonist Therapeutics Inc is the acquisition of 8,000 shares on December 3, 2019, which cost Bryan Giraudo around $45,600.
According to the SEC Form 4 filings, Bryan Giraudo has made a total of 10 transactions in Gossamer Bio Inc (GOSS) over the past 5 years, including 7 buys and 3 sells. The most-recent trade in Gossamer Bio Inc is the acquisition of 100,000 shares on June 18, 2024, which cost Bryan Giraudo around $59,000.
Insider Trading History of Bryan Giraudo
- 1
Bryan Giraudo Trading Performance
GuruFocus tracks the stock performance after each of Bryan Giraudo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryan Giraudo is 22.55%. GuruFocus also compares Bryan Giraudo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryan Giraudo within 3 months outperforms 8 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bryan Giraudo's insider trading performs compared to the benchmark.
Performance of Bryan Giraudo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25.1 | | | | | |
| Relative Return to S&P 500(%) | 21.5 | | | | | |
Bryan Giraudo Ownership Network
Ownership Network List of Bryan Giraudo
Ownership Network Relation of Bryan Giraudo
Bryan Giraudo Owned Company Details
What does Gossamer Bio Inc do?
Who are the key executives at Gossamer Bio Inc?
Bryan Giraudo is the Chief Financial Officer of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include Chief Medical Officer Richard Aranda , director & Executive Chairman Faheem Hasnain , and EVP & General Counsel Waage Christian .
Gossamer Bio Inc (GOSS) Insider Trades Summary
Over the past 18 months, Bryan Giraudo made 3 insider transaction in Gossamer Bio Inc (GOSS) with a net purchase of 293,570. Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 348,828 shares made by Faheem Hasnain , a net sale of 5,926 shares made by Richard Aranda , and a net purchase of 32,000 shares made by Sandra Milligan .
In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,976 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 683,024 shares.
Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gossamer Bio Inc Insider Transactions
Bryan Giraudo Mailing Address
Above is the net worth, insider trading, and ownership report for Bryan Giraudo. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Bryan Giraudo's mailing address is: Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
